share_log

Marinus Pharmaceuticals Expects That Cash, Cash Equivalents And Short-term Investments Of $113.3M As Of March 31, 2024, Inclusive Of Cost Reduction Plans, Is Expected To Provide Cash Runway Into Q1 Of 2025

Benzinga ·  May 8 07:11
Marinus Pharmaceuticals Expects That Cash, Cash Equivalents And Short-term Investments Of $113.3M As Of March 31, 2024, Inclusive Of Cost Reduction Plans, Is Expected To Provide Cash Runway Into Q1 Of 2025
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment